Lifecore Biomedical
Mat Pralle is an experienced finance professional with a strong background in accounting and assurance. Since August 2017, Mat has served as the Controller at Lifecore Biomedical, building on previous experience as Accounting Manager. Prior to this role, Mat held various positions at Ernst & Young from June 2006 to December 2016, advancing from Audit Intern to Senior Manager - Assurance. Mat also gained valuable auditing experience as an intern at LarsonAllen. Mat holds a Bachelor's degree in Accounting from the University of Northern Iowa, obtained in 2007.
Lifecore Biomedical
Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. From formulation to commercialization, we have everything it takes to move your project to the next level, making progress possible for our partners, people and most importantly, patients. Working from two dedicated, state-of-the-art facilities, our people are subject matter experts, our capabilities customized, our processes and systems qualified and our infrastructure optimized to meet your most sophisticated requirements regardless of scale. Our expertise is in drug products that are challenging and difficult to formulate, sterile filter, and aseptically fill. We've been the global leader in pharmaceutical-grade sodium hyaluronate (NaHy) for nearly 40 years. Leveraging this experience alongside deep expertise and capabilities in highly viscous solutions, we create tailored solutions that solve your drug development challenges across the entire development and manufacturing lifecycle. Our capabilities: Sterile Injectable Development - Formulation Development - Sterilization Development - Process Development - Analytical Services & Stability - Engineering Services - Validation Services Sterile Injectable Manufacturing - Sterilization - Aseptic Filling - Packaging - Analytical Services & Stability